1. Home
  2. GOGL vs NVAX Comparison

GOGL vs NVAX Comparison

Compare GOGL & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOGL
  • NVAX
  • Stock Information
  • Founded
  • GOGL N/A
  • NVAX 1987
  • Country
  • GOGL Bermuda
  • NVAX United States
  • Employees
  • GOGL N/A
  • NVAX N/A
  • Industry
  • GOGL Marine Transportation
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GOGL Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • GOGL Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • GOGL 1.4B
  • NVAX 1.3B
  • IPO Year
  • GOGL 1997
  • NVAX 1995
  • Fundamental
  • Price
  • GOGL $8.25
  • NVAX $6.93
  • Analyst Decision
  • GOGL Hold
  • NVAX Buy
  • Analyst Count
  • GOGL 2
  • NVAX 5
  • Target Price
  • GOGL $10.25
  • NVAX $16.60
  • AVG Volume (30 Days)
  • GOGL 2.5M
  • NVAX 4.8M
  • Earning Date
  • GOGL 08-27-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • GOGL 12.73%
  • NVAX N/A
  • EPS Growth
  • GOGL N/A
  • NVAX N/A
  • EPS
  • GOGL 0.57
  • NVAX 2.97
  • Revenue
  • GOGL $863,612,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • GOGL N/A
  • NVAX $56.85
  • Revenue Next Year
  • GOGL $11.09
  • NVAX N/A
  • P/E Ratio
  • GOGL $14.78
  • NVAX $2.35
  • Revenue Growth
  • GOGL N/A
  • NVAX 25.92
  • 52 Week Low
  • GOGL $6.27
  • NVAX $5.01
  • 52 Week High
  • GOGL $13.50
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • GOGL 61.54
  • NVAX 51.12
  • Support Level
  • GOGL $7.76
  • NVAX $6.54
  • Resistance Level
  • GOGL $8.42
  • NVAX $7.20
  • Average True Range (ATR)
  • GOGL 0.21
  • NVAX 0.28
  • MACD
  • GOGL 0.07
  • NVAX 0.06
  • Stochastic Oscillator
  • GOGL 85.34
  • NVAX 66.36

About GOGL Golden Ocean Group Limited

Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts. The Company's single operating segment derives revenue from transporting dry bulk cargoes and chartering vessels to customers on time charter or voyage charter contracts.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: